Regencell Bioscience (RGC) Earnings (2019 - 2025)
Regencell Bioscience (RGC) earnings from Jun 30, 2019 to Jun 30, 2025. The TTM Regencell Bioscience (RGC) earnings is -$3.58M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Regencell Bioscience (RGC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -16.74% |
| 3 Years | -21.67% |
| 5 Years | +34.61% |
| All Time | +44.69% |
Annual Earnings change of Regencell Bioscience (RGC)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$3.58M | -16.74% |
| 2024 | -$4.30M | -26.75% |
| 2023 | -$5.87M | -21.21% |
| 2022 | -$7.45M | +451.85% |
| 2021 | -$1.35M | +66.67% |
| 2020 | -$810K | +107.69% |
| 2019 | -$390K | N/A |
Comparison Regencell Bioscience (RGC) five years earnings CAGR with competitors
Regencell Bioscience (RGC) five years earnings CAGR is 34.56%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +188.43% |
| TLRY | Tilray Brands Inc | 57.78% | +67.16% |
| PRGO | Perrigo Company plc | 51.08% | +47.79% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | -17.89% |
| UTHR | United Therapeutics Corp | 26.00% | -24.78% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -37.33% |
| AYTU | Aytu BioPharma Inc | 21.24% | -38.54% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -49.98% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -51.01% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -65.78% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -69.01% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -69.81% |
| ZTS | Zoetis Inc - Class A | 8.54% | -75.30% |
| KMDA | Kamada Ltd | 6.87% | -80.12% |
| PRFX | PRF Technologies Ltd | 6.09% | -82.38% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -85.46% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -89.15% |
| CPHI | China Pharma Holdings Inc | 3.58% | -89.64% |
| BHC | Bausch Health Companies Inc | 3.48% | -89.93% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -91.51% |